Abstract
The psychostimulant methylphenidate was used to treat 30 depressed cancer patients in whom rapid response and minimization of the usual side effects of tricyclic antidepressants were desirable. Ten showed marked improvement and 13 moderate improvement, achieved within days and with few side effects. Eleven of these patients were treated for a year without evidence of tolerance or abuse.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
